关键信息
-
基因名
def
- 应用
-
别名
Polypeptide deformylase
-
种属
Escherichia coli O157:H7
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0A6K5
-
表达区间
2-169aa
-
分子量
35.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
Defensins are a family of small, cationic peptides that play a crucial role in the innate immune response across a wide range of organisms, including plants, insects, and mammals. These proteins are known for their antimicrobial properties, providing a first line of defense against pathogens such as bacteria, fungi, and viruses. Research into defensins has gained prominence due to their potential therapeutic applications, especially in the context of rising antibiotic resistance. Additionally, defensins exhibit various biological activities, including immunomodulation and wound healing, making them attractive candidates for drug development. The study of defensin recombinants is particularly important as it allows researchers to explore structure-function relationships, enhance peptide stability and activity, and produce these molecules at a larger scale for clinical and agricultural applications. By employing recombinant DNA technology, scientists can express and purify defensins in heterologous systems, facilitating detailed biochemical studies and the design of novel therapeutics. Overall, the investigation of defensin recombinants has significant implications for enhancing our understanding of host defense mechanisms and developing innovative solutions to combat infectious diseases.
